Kathy D. Miller, MD and Alexandra Thomas, MD

Best Practices in HR+/HER2- Breast Cancer

Publish date: January 30, 2023

Leading oncologists discuss best practices in treatment of HR+/HER2- breast cancer, including use of trastuzumab deruxtec...